Did you know ? If you order before Friday 14h we deliver 90PCT of the the time next Tuesday, GENTAUR another in time delivery

Pubmed ID :20664001
Publication Date : //

Negative regulatory effects of Mnk kinases in the generation of chemotherapy-induced antileukemic responses.


Mnk kinases are downstream effectors of mitogen-activated protein kinase pathways and mediate phosphorylation of the eukaryotic initiation factor (eIF4E), a protein that plays a key role in the regulation of mRNA translation and is up-regulated in acute myeloid leukemia (AML). We determined the effects of chemotherapy (cytarabine) on the activation status of Mnk in AML cells and its role in the generation of antileukemic responses. A variety of experimental approaches were used, including immunoblotting, apoptosis assays, small interfering RNA (siRNA)-mediated knockdown of proteins, and clonogenic hematopoietic progenitor assays in methylcellulose. Cytarabine induced phosphorylation/activation of Mnk and Mnk-mediated phosphorylation of eIF4E on Ser209, as evidenced by studies involving pharmacological inhibition of Mnk or experiments using cells with targeted disruption of Mnk1 and Mnk2 genes. To assess the functional relevance of cytarabine-inducible engagement of Mnk/eIF4E pathway, the effects of pharmacological inhibition of Mnk on cytarabine-mediated suppression of primitive leukemic progenitors [leukemic colony forming unit (CFU-L)] were examined. Concomitant treatment of cells with a pharmacological inhibitor of Mnk or siRNA-mediated knockdown of Mnk1/2 strongly enhanced the suppressive effects of low cytarabine concentrations on CFU-L. It is noteworthy that the mammalian target of rapamycin (mTOR) inhibitor rapamycin also induced phosphorylation of eIF4E in a Mnk-dependent manner, whereas inhibition strongly enhanced its antileukemic effects. These data demonstrate that Mnk kinases are activated in a negative-feedback regulatory manner in response to chemotherapy and impair the generation of antileukemic responses. They also identify this pathway as a novel target for the design of new approaches to enhance the antileukemic effects of chemotherapy or mTOR inhibitors in AML.

Authors : Altman Jessica K , Glaser Heather , Sassano Antonella , Joshi Sonali , Ueda Takeshi , Watanabe-Fukunaga Rie , Fukunaga Rikiro , Tallman Martin S , Platanias Leonidas C ,

Related products :

Catalog number Product name Quantity
24073 Primary antibody DRAK1 Antibody, Source Rabbit, Species Reactivity No cross responses to DRAK2, DAP or ZIP kinases. 100ug
30-204 Retinoids exert biologic effects such as potent growth inhibitory and cell differentiation activities and are used in the treatment of hyperproliferative dermatological diseases. These effects are med 0.1 mg
24074 Primary antibody DRAK2 Antibody, Source Rabbit, Species Reactivity It has no cross responses to DAP or ZIP kinases. The approximately 70 kDa band is probably non-related to DRAK2 although it is pe 100ug
30-337 NDRG1 is a member of the N-myc downregulated protein family which belongs to the alpha_beta hydrolase superfamily. NDRG1 is a cytoplasmic protein involved in stress responses, hormone responses, cell 0.1 mg
30-338 NDRG1 is a member of the N-myc downregulated protein family which belongs to the alpha_beta hydrolase superfamily. NDRG1 is a cytoplasmic protein involved in stress responses, hormone responses, cell 0.1 mg
orb60893 Matrine((+)-Matrine) Matrine((+)-Matrine) is an alkaloid found in plants from the Sophora family. It has a variety of pharmacological effects, including anti-cancer effects, and action as a kappa opio 50 mg
pka-010 Recombinant Human PTEN Induced Putative Kinase 1 PROTEIN KINASES 1mg
pka-010 Recombinant Human PTEN Induced Putative Kinase 1 PROTEIN KINASES 20
pka-010 Recombinant Human PTEN Induced Putative Kinase 1 PROTEIN KINASES 5
E14824h Human Cyclin Dependent Kinases Regulatory Subunit 96T
E2579h Human Cyclin Dependent Kinases Regulatory Subunit 96T
orb61352 Paclitaxel Antitumor and antileukemic agent isolated from the bark of the yew tree For research use only. 1 g
orb61315 Bryostatin 1 Bryostatin 1 binds to and activates protein kinase C, but its biological effects differ greatly from those induced by other protein kinase C activators. For research use only. 10 ug
pka-328 Recombinant bovine Phosphoinositide 3-kinase a regulatory subunit PROTEIN KINASES 2
pka-328 Recombinant bovine Phosphoinositide 3-kinase a regulatory subunit PROTEIN KINASES 10
pka-328 Recombinant bovine Phosphoinositide 3-kinase a regulatory subunit PROTEIN KINASES 20
CKS1_BOVIN Bovine ELISA Kit FOR Cyclin-dependent kinases regulatory subunit 1 96T
CSB-EL005464BO Bovine Cyclin-dependent kinases regulatory subunit 1(CKS1B) ELISA kit 96T
CSB-EL005468BO Bovine Cyclin-dependent kinases regulatory subunit 2(CKS2) ELISA kit 96T
CSB-EL005468HU Human Cyclin-dependent kinases regulatory subunit 2(CKS2) ELISA kit 96T
CSB-EL005464HU Human Cyclin-dependent kinases regulatory subunit 1(CKS1B) ELISA kit 96T
EIAAB07619 Bos taurus,Bovine,CKS2,CKS-2,Cyclin-dependent kinases regulatory subunit 2
EIAAB07618 Cks2,CKS-2,Cyclin-dependent kinases regulatory subunit 2,Mouse,Mus musculus
CSB-EL005468MO Mouse Cyclin-dependent kinases regulatory subunit 2(CKS2) ELISA kit 96T
CSB-EL005464MO Mouse Cyclin-dependent kinases regulatory subunit 1(CKS1B) ELISA kit 96T


 

GENTAUR Belgium BVBA BE0473327336
Voortstraat 49, 1910 Kampenhout BELGIUM
Tel 0032 16 58 90 45

Fax 0032 16 50 90 45
info@gentaur.com | Gentaur | Gentaur





GENTAUR Ltd.
Unicorn House, Station Cl
Hertfordshire, Potters Bar EN6 1TL
Whetstone London N20 9BH
Tel 020 3393 8531 Fax 020 8445 9411
uk@gentaur.com | Gentaur | Gentaur

 

 




GENTAUR France SARL
9, rue Lagrange, 75005 Paris
Tel 01 43 25 01 50

Fax 01 43 25 01 60
RCS Paris B 484 237 888

SIRET 48423788800017
RIB 30004 00187 00010092253 10
BNP PARIBAS PARIS PL MAUBERT BIC BNPAFRPPPRG
IBAN FR76 3000 4001 8700 0100 9225 310
france@gentaur.com | Gentaur | Gentaur

GENTAUR GmbH
Marienbongard 20
52062 Aachen Deutschland
Support Karolina Elandt
Tel: 0035929830070
Fax: (+49) 241 56 00 47 88

Logistic :0241 40 08 90 86
Bankleitzahl 39050000
IBAN lautet DE8839050000107569353
Handelsregister Aachen HR B 16058
Umsatzsteuer-Identifikationsnummer *** DE 815175831
Steuernummer 201/5961/3925
de@gentaur.com | Gentaur | Gentaur

GENTAUR U.S.A
Genprice Inc, Logistics
547, Yurok Circle
San Jose, CA 95123
CA 95123
Tel (408) 780-0908,
Fax (408) 780-0908,
sales@genprice.com

Genprice Inc, Invoices and accounting
6017 Snell Ave, Ste 357
San Jose, CA 95123




GENTAUR Nederland BV
NL850396268B01 KVK nummer 52327027
Kuiper 1
5521 DG Eersel Nederland
Tel:  0208-080893  Fax: 0497-517897
nl@gentaur.com | Gentaur | Gentaur
IBAN: NL04 RABO 0156 9854 62   SWIFT RABONL2U






GENTAUR Spain
tel:0911876558
spain@gentaur.com | Gentaur | Gentaur






ГЕНТАУЪР БЪЛГАРИЯ
ID # 201 358 931 /BULSTAT
София 1000, ул. "Граф Игнатиев" 53 вх. В, ет. 2
Tel 0035924682280 Fax 0035924808322
e-mail: Sofia@gentaur.com | Gentaur | Gentaur
IBAN: BG11FINV91501014771636
BIC: FINVBGSF

GENTAUR Poland Sp. z o.o.


ul. Grunwaldzka 88/A m.2
81-771 Sopot, Poland
TEL Gdansk 058 710 33 44 FAX  058 710 33 48              

poland@gentaur.com | Gentaur | Gentaur

Other countries

Österreich +43720880899

Canada Montreal +15149077481

Ceská republika Praha +420246019719

Danmark +4569918806

Finland Helsset +358942419041

Magyarország Budapest +3619980547

Ireland Dublin+35316526556

Luxembourg+35220880274

Norge Oslo+4721031366

Sverige Stockholm+46852503438

Schweiz Züri+41435006251

US New York+17185132983

GENTAUR Italy
SRL IVA IT03841300167
Piazza Giacomo Matteotti, 6
24122 Bergamo Tel 02 36 00 65 93
Fax 02 36 00 65 94
italia@gentaur.com | Gentaur | Gentaur